secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
CIK:        0001979414
Form:       8-K
Filed at:   2025-10-10T23:59:59+00:00
Accession:  0001829126-25-008052
Event type: other_material
Sentiment:  positive
Materiality: 0.85
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NeOnc sets Oct 23 closing for $50M partnership with Quazar Investment after UAE approvals
--------------------------------------------------------------------------------

- Closing of $50M strategic partnership with Quazar Investment by Oct 23 after UAE tax/regulatory approvals.
- $15M of funds allocated for Phase 2B clinical trials and infrastructure in UAE and MENA region.
- Four upcoming clinical trials: NEO100-01, NEO100-02, NEO212 (Phase 2a/2b), and NEO100-03 (Phase 1 pediatric).
- NuroMENA Holdings, the Abu Dhabi-based operating subsidiary, incorporated on August 6, 2025.
- Quazar Investment has over $3.3B in AUM; partnership involves significant equity investment in NeOnc.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1979414/000182912625008052/0001829126-25-008052-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1979414/000182912625008052/neonctechnologies_8k.htm
  HTML page:      https://secwatch.observer/filing/0001829126-25-008052

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer